AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue

Navigation

Page 38 of 55

39 9.1. Revascularization for Claudication COR LOE Recommendations Revascularization for Claudication: Infrapopliteal Disease 2b C-LD 8. In patients with functionally limiting claudication and isolated hemodynamically significant infrapopliteal disease with inadequate response to GDMT (including structured exercise), the effectiveness of endovascular revascularization is unknown 2b C-LD 9. In patients with functionally limiting claudication and isolated hemodynamically significant infrapopliteal disease with inadequate response to GDMT (including structured exercise), the effectiveness of surgical revascularization is unknown. 9.2. Conduit for Surgical Revascularization for Femoropopliteal Disease COR LOE Recommendation 1 A 1. In patients who are undergoing surgical revascularization for functionally limiting claudication and hemodynamically significant femoropopliteal disease, bypass to the popliteal artery with autogenous vein is recommended in preference to prosthetic graft material. Multispecialty care team Revascularization (endovascular, surgical, hybrid) Wound care and management of infection Pressure offloading Selective amputation (most distal level possible) Antiplatelet and antithrombotic therapy and cardiovascular risk reduction Figure 6. Components of Care for CLTI (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024